Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal
about
Transmembrane transporter expression regulated by the glucosylceramide pathway in Cryptococcus neoformans.Role of glucose in the expression of Cryptococcus neoformans antiphagocytic protein 1, App1.Synthesis and biological properties of fungal glucosylceramide.Toward developing a universal treatment for fungal disease using radioimmunotherapy targeting common fungal antigensIdentification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids.Methylation of glycosylated sphingolipid modulates membrane lipid topography and pathogenicity of Cryptococcus neoformans.Glucosylceramide Administration as a Vaccination Strategy in Mouse Models of Cryptococcosis.Detection of antibody against fungal glucosylceramide in immunocompromised patients: a potential new diagnostic approach for cryptococcosis.Unravelling secretion in Cryptococcus neoformans: more than one way to skin a cat.Fungal glucosylceramides: from structural components to biologically active targets of new antimicrobials.Vesicular transport systems in fungiRadioimmunotherapy of fungal diseases: the therapeutic potential of cytocidal radiation delivered by antibody targeting fungal cell surface antigens.Sphingolipids as targets for treatment of fungal infectionsChanges in glucosylceramide structure affect virulence and membrane biophysical properties of Cryptococcus neoformans.Characterization of the antifungal functions of a WGA-Fc (IgG2a) fusion protein binding to cell wall chitin oligomersInositol phosphosphingolipid phospholipase C1 regulates plasma membrane ATPase (Pma1) stability in Cryptococcus neoformans.Chemotaxis and adherence to fungal surfaces are key components of the behavioral response of Burkholderia terrae BS001 to two selected soil fungi.
P2860
Q30278081-3EE0BEFA-C127-480B-9B1B-0465E12C433FQ34739562-072056D7-9DCF-45BA-AE48-F3351EB69B77Q35084966-F8522AD3-BBC6-4CA6-9850-ACF9139CABD2Q35422542-C0ABEBC3-F3EA-4DA8-9D77-313C3450B5CDQ35672458-23E8DBF5-8551-4A45-BFF7-048F22AF5BA2Q35827998-763C774B-EB49-4CA1-A493-18649AE9B8FDQ35991081-2BB67DEA-C51F-4B56-964B-E7D7B021E878Q37444556-D7DF136D-1CB0-4CC1-91A7-4422928B59ECQ37928507-358C69D1-DA0B-49CC-AD56-31A11723CF6BQ37949339-39AF6C8D-6670-40AA-B2C9-FE6DE1C18FD6Q37955954-94367D75-5A8C-423F-B9C6-1C4C8BADC0E6Q37978622-EDCA3AD4-694E-4FE4-9005-2B33D4DD1906Q38833311-68E43F12-22ED-4A87-A6E5-A59317E4407EQ40069608-0D44B861-8D78-4E2E-AEC1-23158FC2061FQ41842506-F9BE3E28-3043-4771-8B35-4991124C3B5AQ42266243-B5892D97-98D8-4D23-B022-AF4298659FF4Q51275131-7635732D-169F-4CFE-9787-F84B9ECC3459
P2860
Surface localization of glucosylceramide during Cryptococcus neoformans infection allows targeting as a potential antifungal
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Surface localization of glucos ...... ting as a potential antifungal
@ast
Surface localization of glucos ...... ting as a potential antifungal
@en
Surface localization of glucos ...... ting as a potential antifungal
@nl
type
label
Surface localization of glucos ...... ting as a potential antifungal
@ast
Surface localization of glucos ...... ting as a potential antifungal
@en
Surface localization of glucos ...... ting as a potential antifungal
@nl
prefLabel
Surface localization of glucos ...... ting as a potential antifungal
@ast
Surface localization of glucos ...... ting as a potential antifungal
@en
Surface localization of glucos ...... ting as a potential antifungal
@nl
P2093
P2860
P3181
P1433
P1476
Surface localization of glucos ...... ting as a potential antifungal
@en
P2093
Arpita Singh
Chiara Luberto
Giulia Morace
Maurizio Del Poeta
Monica Drago
Ryan Rhome
Talar Kechichian
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0015572
P407
P577
2011-01-21T00:00:00Z